1. Home
  2. ITRN vs MNKD Comparison

ITRN vs MNKD Comparison

Compare ITRN & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

HOLD

Current Price

$66.32

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.66

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRN
MNKD
Founded
1994
1991
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2005
2004

Fundamental Metrics

Financial Performance
Metric
ITRN
MNKD
Price
$66.32
$3.66
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
$60.67
$8.69
AVG Volume (30 Days)
135.0K
4.9M
Earning Date
05-26-2026
05-06-2026
Dividend Yield
3.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$348,966,000.00
Revenue This Year
$12.38
$35.81
Revenue Next Year
$8.21
$11.89
P/E Ratio
$16.85
N/A
Revenue Growth
N/A
22.23
52 Week Low
$32.71
$2.23
52 Week High
$68.30
$6.51

Technical Indicators

Market Signals
Indicator
ITRN
MNKD
Relative Strength Index (RSI) 68.94 60.57
Support Level $55.33 $3.30
Resistance Level $68.30 $3.94
Average True Range (ATR) 2.84 0.22
MACD 0.00 0.01
Stochastic Oscillator 86.34 60.16

Price Performance

Historical Comparison
ITRN
MNKD

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: